Trial of calcium to prevent preeclampsia
- PMID: 9211675
- DOI: 10.1056/NEJM199707103370201
Trial of calcium to prevent preeclampsia
Abstract
Background: Previous trials have suggested that calcium supplementation during pregnancy may reduce the risk of preeclampsia. However, differences in study design and a low dietary calcium intake in the populations studied limit acceptance of the data.
Methods: We randomly assigned 4589 healthy nulliparous women who were 13 to 21 weeks pregnant to receive daily treatment with either 2 g of elemental calcium or placebo for the remainder of their pregnancies. Surveillance for preeclampsia was conducted by personnel unaware of treatment-group assignments, using standardized measurements of blood pressure and urinary protein excretion at uniformly scheduled prenatal visits, protocols for monitoring these measurements during the hospitalization for delivery, and reviews of medical records of unscheduled outpatient visits and all hospitalizations.
Results: Calcium supplementation did not significantly reduce the incidence or severity of preeclampsia or delay its onset. Preeclampsia occurred in 158 of the 2295 women in the calcium group (6.9 percent) and 168 of the 2294 women in the placebo group (7.3 percent) (relative risk, 0.94; 95 percent confidence interval, 0.76 to 1.16). There were no significant differences between the two groups in the prevalence of pregnancy-associated hypertension without preeclampsia (15.3 percent vs. 17.3 percent) or of all hypertensive disorders (22.2 percent vs. 24.6 percent). The mean systolic and diastolic blood pressures during pregnancy were similar in both groups. Calcium did not reduce the numbers of preterm deliveries, small-for-gestational-age births, or fetal and neonatal deaths; nor did it increase urolithiasis during pregnancy.
Conclusions: Calcium supplementation during pregnancy did not prevent preeclampsia, pregnancy-associated hypertension, or adverse perinatal outcomes in healthy nulliparous women.
Comment in
-
Prevention or early treatment of preeclampsia.N Engl J Med. 1997 Jul 10;337(2):124-5. doi: 10.1056/NEJM199707103370209. N Engl J Med. 1997. PMID: 9211683 No abstract available.
Similar articles
-
Calcium supplementation to prevent hypertensive disorders of pregnancy.N Engl J Med. 1991 Nov 14;325(20):1399-405. doi: 10.1056/NEJM199111143252002. N Engl J Med. 1991. PMID: 1922250 Clinical Trial.
-
Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.N Engl J Med. 1993 Oct 21;329(17):1213-8. doi: 10.1056/NEJM199310213291701. N Engl J Med. 1993. PMID: 8413387 Clinical Trial.
-
Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.N Engl J Med. 1998 Mar 12;338(11):701-5. doi: 10.1056/NEJM199803123381101. N Engl J Med. 1998. PMID: 9494145 Clinical Trial.
-
Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.CMAJ. 1997 Oct 1;157(7):907-19. CMAJ. 1997. PMID: 9327800 Free PMC article. Review.
-
Calcium supplementation and prevention of preeclampsia: a meta-analysis.J Matern Fetal Neonatal Med. 2012 Dec;25(12):2570-4. doi: 10.3109/14767058.2012.715220. Epub 2012 Aug 24. J Matern Fetal Neonatal Med. 2012. PMID: 22889274 Review.
Cited by
-
Early-pregnancy N-terminal pro-brain natriuretic peptide level is inversely associated with hypertensive disorders of pregnancy diagnosed after 35 weeks of gestation.Sci Rep. 2024 May 28;14(1):12225. doi: 10.1038/s41598-024-63206-5. Sci Rep. 2024. PMID: 38806648 Free PMC article.
-
Calcium supplementation to prevent pre-eclampsia: protocol for an individual participant data meta-analysis, network meta-analysis and health economic evaluation.BMJ Open. 2023 May 11;13(5):e065538. doi: 10.1136/bmjopen-2022-065538. BMJ Open. 2023. PMID: 37169508 Free PMC article.
-
Dietary supplements and vascular function in hypertensive disorders of pregnancy.Pflugers Arch. 2023 Jul;475(7):889-905. doi: 10.1007/s00424-023-02810-2. Epub 2023 Apr 12. Pflugers Arch. 2023. PMID: 37043045 Free PMC article. Review.
-
Medications for preventing hypertensive disorders in high-risk pregnant women: a systematic review and network meta-analysis.Syst Rev. 2022 Jul 1;11(1):135. doi: 10.1186/s13643-022-01978-5. Syst Rev. 2022. PMID: 35778751 Free PMC article.
-
Cohort profile: the Olmsted County hypertensive disorders of pregnancy (HDP) cohort using the Rochester Epidemiology Project.BMJ Open. 2022 Apr 26;12(4):e055057. doi: 10.1136/bmjopen-2021-055057. BMJ Open. 2022. PMID: 35473734 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical